Bupropion for overweight women with binge-eating disorder: A randomized, double-blind, placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 74, Issue 4, 2013, Pages 400-406

  White, Marney A ^a   Grilo, Carlos M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BINGE EATING DISORDER; BODY MASS; CONTROLLED STUDY; DEPRESSION; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SHORT COURSE THERAPY; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

EID: 84876537144     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m08071     Document Type: Article

References (52)

1. American Psychiatric Association. Diagnostic and Statistical Manualof Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Hudson JI, Hiripi E, Pope HG Jr, et al. The prevalence and correlates of eatingdisorders in the National Comorbidity Survey Replication. Biol Psychiatry.2007;61(3):348-358.
3. Grilo CM, Crosby RD, Masheb RM, et al. Overvaluation of shape and weightin binge eating disorder, bulimia nervosa, and sub-threshold bulimia nervosa.Behav Res Ther. 2009;47(8):692-696.
4. Grilo CM, Hrabosky JI, White MA, et al. Overvaluation of shape and weightin binge eating disorder and overweight controls: refinement of a diagnosticconstruct. J Abnorm Psychol. 2008;117(2):414-419.
5. Wonderlich SA, Gordon KH, Mitchell JE, et al. The validity and clinicalutility of binge eating disorder. Int J Eat Disord. 2009;42(8):687-705.
6. Reas DL, Grilo CM. Review and meta-analysis of pharmacotherapy forbinge-eating disorder. Obesity (Silver Spring). 2008;16(9):2024-2038.
7. McElroy SL, Casuto LS, Nelson EB, et al. Placebo-controlled trial of sertralinein the treatment of binge eating disorder. Am J Psychiatry. 2000;157(6):1004-1006.
8. Grilo CM, Masheb RM, Wilson GT. Efficacy of cognitive behavioral therapyand fluoxetine for the treatment of binge eating disorder: a randomizeddouble-blind placebo-controlled comparison. Biol Psychiatry. 2005;57(3):301-309.
9. Arnold LM, McElroy SL, Hudson JI, et al. A placebo-controlled, randomizedtrial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry.2002;63(11):1028-1033.
10. Ricca V, Mannucci E, Mezzani B, et al. Fluoxetine and fluvoxamine combinedwith individual cognitive-behaviour therapy in binge eating disorder: A one-year follow-up study. Psychother Psychosom. 2001;70(6):298-306.
11. Golay A, Laurent-Jaccard A, Habicht F, et al. Effect of orlistat in obesepatients with binge eating disorder. Obes Res. 2005;13(10):1701-1708.
12. Grilo CM, Masheb RM, Salant SL. Cognitive behavioral therapy guided selfhelpand orlistat for the treatment of binge eating disorder: a randomized,double-blind, placebo-controlled trial. Biol Psychiatry. 2005;57(10):1193-1201.
13. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatmentof binge eating disorder associated with obesity: a randomized, placebocontrolledtrial. Am J Psychiatry. 2003;160(2):255-261.
14. Claudino AM, de Oliveira IR, Appolinario JC, et al. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive- behaviortherapy in binge-eating disorder. J Clin Psychiatry. 2007;68(9):1324-1332.
15. McElroy SL, Kotwal R, Guerdjikova AI, et al. Zonisamide in the treatmentof binge eating disorder with obesity: a randomized controlled trial.J Clin Psychiatry. 2006;67(12):1897-1906.
16. Grilo CM, Masheb RM, Wilson GT, et al. Cognitive-behavioral therapy,behavioral weight loss, and sequential treatment for obese patients withbinge-eating disorder: a randomized controlled trial. J Consult Clin Psychol.2011;79(5):675-685.
17. Hudson JI, Lalonde JK, Coit CE, et al. Longitudinal study of the diagnosisof components of the metabolic syndrome in individuals with binge-eatingdisorder. Am J Clin Nutr. 2010;91(6):1568-1573.
18. Wilson GT, Grilo CM, Vitousek KM. Psychological treatment of eatingdisorders. Am Psychol. 2007;62(3):199-216.
19. Collins BN, Wileyto EP, Patterson F, et al. Gender differences in smokingcessation in a placebo-controlled trial of bupropion with behavioralcounseling. Nicotine Tob Res. 2004;6(1):27-37.
20. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained- releasebupropion and placebo for smoking cessation. N Engl J Med. 1997;337(17):1195-1202.
21. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustainedreleasebupropion, a nicotine patch, or both for smoking cessation.N Engl J Med. 1999;340(9):685-691.
22. Fossati R, Apolone G, Negri E, et al; for the General Practice TobaccoCessation Investigators Group. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.Arch Intern Med. 2007;167(16):1791-1797.
23. Brody AL, Mandelkern MA, Lee G, et al. Attenuation of cue-inducedcigarette craving and anterior cingulate cortex activation in bupropiontreatedsmokers: a preliminary study. Psychiatry Res. 2004;130(3):269-281.
24. Jain AK, Kaplan RA, Gadde KM, et al. Bupropion SR vs placebo for weightloss in obese patients with depressive symptoms. Obes Res. 2002;10(10):1049-1056.
25. Li SX, Perry KW, Wong DT. Influence of fluoxetine on the ability ofbupropion to modulate extracellular dopamine and norepinephrineconcentrations in three mesocorticolimbic areas of rats. Neuropharmacology.2002;42(2):181-190.
26. Anderson JW, Greenway FL, Fujioka K, et al. Bupropion SR enhances weightloss: a 48-week double-blind, placebo- controlled trial. Obes Res. 2002;10(7):633-641.
27. Van den Eynde F, Claudino AM, Mogg A, et al. Repetitive transcranialmagnetic stimulation reduces cue-induced food craving in bulimic disorders.Biol Psychiatry. 2010;67(8):793-795.
28. Heatherton TF, Baumeister RF. Binge eating as escape from self-awareness.Psychol Bull. 1991;110(1):86-108.
29. Grilo CM, Masheb RM, Wilson GT. Subtyping binge eating disorder.J Consult Clin Psychol. 2001;69(6):1066-1072.
30. Wellman PJ. Modulation of eating by central catecholamine systems.Curr Drug Targets. 2005;6(2):191-199.
31. Shinohara M, Mizushima H, Hirano M, et al. Eating disorders withbinge-eating behaviour are associated with the s allele of the 3?-UTR VNTRpolymorphism of the dopamine transporter gene. J Psychiatry Neurosci. 2004;29(2):134-137.
32. Horne RL, Ferguson JM, Pope HG Jr, et al. Treatment of bulimia withbupropion: a multicenter controlled trial. J Clin Psychiatry. 1988;49(7):262-266.
33. Weinberger AH, McKee SA, Picciotto MR, et al. Examining antidepressantdrug response by smoking status: why is it important and how often is itdone? J Psychopharmacol. 2011;25(10):1269-1276.
34. Celio AA, Wilfley DE, Crow SJ, et al. A comparison of the Binge Eating Scale,Questionnaire for Eating and Weight Patterns-Revised, and Eating DisorderExamination Questionnaire with instructions with the Eating DisorderExamination in the assessment of binge eating disorder and its symptoms.Int J Eat Disord. 2004;36(4):434-444.
35. First MB, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Version (SCID-I/P, Version 2.0). New York, NY: NY State PsychiatricInstitute; 1996.
36. Fairburn CG, Cooper Z. The Eating Disorder Examination. In: Fairburn CG,Wilson GT, eds. Binge Eating: Nature, Assessment, and Treatment. 12th ed.New York, NY: Guilford Press; 1993:317-360.
37. Grilo CM, Masheb RM, Lozano-Blanco C, et al. Reliability of the EatingDisorder Examination in patients with binge eating disorder. Int J Eat Disord.2004;35(1):80-85.
38. Grilo CM, Masheb RM, Wilson GT. A comparison of different methodsfor assessing the features of eating disorders in patients with binge eatingdisorder. J Consult Clin Psychol. 2001;69(2):317-322.
39. White MA, Whisenhunt BL, Williamson DA, et al. Development andvalidation of the Food-Craving Inventory. Obes Res. 2002;10(2):107-114.
40. White MA, Grilo CM. Psychometric properties of the Food CravingInventory among obese patients with binge eating disorder. Eat Behav.2005;6(3):239-245.
41. Beck AT, Steer R. Manual for Revised Beck Depression Inventory. New York,NY: Psychological Corporation; 1987.
42. Beck AT, Steer R, Garbin MG. Psychometric properties of the BeckDepression Inventory - twenty-five years of evaluation. Clin Psychol Rev.1988;8(1):77-100.
43. Grilo CM, Masheb RM, Wilson GT. Different methods for assessingthe features of eating disorders in patients with binge eating disorder: A replication. Obes Res. 2001;9(7):418-422.
44. Diggle P, Heagerty P, Liang K-Y, et al. Analysis of Longitudinal Data.New York, NY: Oxford University Press. 2002.
45. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzingrepeated-measures data and its reflection in papers published in the Archivesof General Psychiatry. Arch Gen Psychiatry. 2004;61(3):310-317.
46. Cudeck R, Klebe KJ. Multiphase mixed-effects models for repeated measuresdata. Psychol Methods. 2002;7(1):41-63. 10.1037/1082-989X.7.1.41
47. Hedeker D, Gibbons RD. Longitudinal Data Analysis. Hoboken, NJ: JohnWiley & Sons. 2006.
48. Hedeker D, Flay BR, Petraitis J. Estimating individual influences ofbehavioral intentions: an application of random-effects modeling to thetheory of reasoned action. J Consult Clin Psychol. 1996;64(1):109-120.
49. Wilfley DE, Crow SJ, Hudson JI, et al Sibutramine Binge Eating DisorderResearch Group. Efficacy of sibutramine for the treatment of binge eatingdisorder: a randomized multicenter placebo-controlled double-blind study.Am J Psychiatry. 2008;165(1):51-58. 10.176/api.ajp.207.06121970
50. McElroy SL, Guerdjikova AI, Winstanley EL, et al. Acamprosate in thetreatment of binge eating disorder: a placebo-controlled trial. Int J Eat Disord.2011;44(1):81-90.
51. Grilo CM, Masheb RM, Wilson GT. Rapid response to treatment for bingeeating disorder. J Consult Clin Psychol. 2006;74(3):602-613.
52. Grilo CM, Crosby RD, Wilson GT, et al. 12-month follow-up of fluoxetineand cognitive behavioral therapy for binge eating disorder. J Consult ClinPsychol. 2012;80(6):1108-1113.